Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENTOCIR: Pentoxifylline in Severe Cirrhosis
NCT00162552Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2004
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cirrhosis and liver failure comparing Pentoxifylline with Placebo (2 arms). Primary endpoint: Survival Rate at 2 Months. Started Aug 2004; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Cirrhosisliver failure
Beyond the preview
Go deeper on NCT00162552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00162552.